Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its Covid-19 vaccine in India. <br /> <br />Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India (DCGI) for its Covid-19 vaccine in the country, after it secured such clearance in the UK and Bahrain. <br /> <br /> Pfizer will continue to engage with the authority and resubmit its approval request with additional information as it becomes available in the near future, the statement said.
